0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

In Vivo and In Vitro Resistance to Sulfadiazine in Strains of Neisseria Meningitidis

Jack W. Millar, MC; Eugene E. Siess, MC; Harry A. Feldman, MD; Carl Silverman, MD; Paul Frank, MA
JAMA. 1963;186(2):139-141. doi:10.1001/jama.1963.63710020008016.
Text Size: A A A
Published online

MENINGOCOCCAL INFECTIONS are relatively common at military recruit camps. In World War I, for example, carrier rates of 60% or more were commonplace throughout the US camps and the number of clinical cases of meningococcal disease were appropriately great. During World War II an outbreak of meningococcal disease began among military bases and spread to the US civilian population. Before the epidemic had run its course during the years 1943 and 1944, some 34,000 persons had become ill and 4,700 of them had died as a result of meningococcal disease.

At the beginning of World War II, a number of workers throughout the world1-5 had reported the use of sulfonamides for treatment of meningococcal meningitis and had, in addition, indicated that sulfonamides might be used to eliminate the meningococcal carrier state in otherwise healthy individuals, thereby limiting the spread of infection to susceptible persons. In 1943 Awe, Babione,

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();